EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

Alexander Biederstädt, Rafet Basar, Jeong-Min Park, Nadima Uprety, Rejeena Shrestha, Francia Reyes Silva, Merve Dede, John Watts, Sunil Acharya, Donghai Xiong, Bin Liu, May Daher und 24 weitere

Cancer Cell · 2025-11 · 43 (11) · 2069-2088.e11

DOI: 10.1016/j.ccell.2025.07.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-11. Verfasst von Alexander Biederstädt und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Immunotherapy, Adoptive, CRISPR-Cas Systems, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, University of Texas MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive cell therapy using engineered natural killer (NK) cells is a promising approach for cancer treatment, with targeted gene editing offering the potential to further enhance their therapeutic efficacy. However, the spectrum of actionable genetic targets to overcome tumor and microenvironment-mediated immunosuppression remains largely unexplored. We performed multiple genome-wide CRISPR screens in primary human NK cells and identified critical checkpoints regulating resistance to immunosuppressive pressures. Ablation of MED12, ARIH2, and CCNC significantly improved NK cell antitumor activity against multiple treatment-refractory human cancers in vitro and in vivo. CRISPR editing augmented both innate and CAR-mediated NK cell function, associated with enhanced metabolic fitness, increased secretion of proinflammatory cytokines, and expansion of cytotoxic NK cell subsets. Through high-content genome-wide CRISPR screening in NK cells, this study reveals critical regulators of NK cell function and provides a valuable resource for engineering next-generation NK cell therapies with improved efficacy against cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalImmunotherapy, AdoptiveCRISPR-Cas SystemsReceptors, Chimeric AntigenNeoplasmsClustered Regularly Interspaced Short Palindromic RepeatsHumansAnimalsGene EditingMiceXenograft Model Antitumor AssaysCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

CAR-NK cell therapyadoptive cell therapyfunctional perturbomicsgenome-wide CRISPR screensmetabolic reprogrammingmultiplexed cellular engineeringnatural killer cellsprecision gene editingsolid tumorstumor microenvironment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell Therapy Discovery and Innovation, The University of Texas MD Anderson…
  • Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Neurology, the University of Texas McGovern Medical School at Houston, Houston, TX, USA.
  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health National Cancer Institute
  • Cockrell Foundation
  • Marcus Foundation
  • Cancer Prevention and Research Institute of Texas
  • Tanoto Foundation

Zitieren

APA

Biederstädt, A., Basar, R., Park, J. M., Uprety, N., Shrestha, R., Reyes Silva, F., Dede, M., Watts, J., Acharya, S., Xiong, D., Liu, B., Daher, M., Rafei, H., Banerjee, P., Li, P., Islam, S., Fan, H., Shanley, M., Jin, J., …, & Rezvani, K. (2025). Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency. Cancer Cell, 43(11), 2069-2088.e11. https://doi.org/10.1016/j.ccell.2025.07.021

Vancouver

Biederstädt A, Basar R, Park JM, Uprety N, Shrestha R, Reyes Silva F, et al. Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency. Cancer Cell. 2025;43(11):2069-2088.e11. doi:10.1016/j.ccell.2025.07.021

BibTeX
@article{Biederstdt2025,
  author = {Biederstädt, Alexander and Basar, Rafet and Park, Jeong-Min and Uprety, Nadima and Shrestha, Rejeena and Reyes Silva, Francia and Dede, Merve and Watts, John and Acharya, Sunil and Xiong, Donghai and Liu, Bin and Daher, May and Rafei, Hind and Banerjee, Pinaki and Li, Ping and Islam, Sanjida and Fan, Huihui and Shanley, Mayra and Jin, Jingling and Kumar, Bijender and Woods, Vernikka and Lin, Paul and Tiberti, Silvia and Nunez Cortes, Ana Karen and Jiang, Xin Ru and Biederstädt, Inci and Zhang, Patrick and Li, Ye and Rawal, Seema and Liu, Enli and Muniz-Feliciano, Luis and Deyter, Gary M and Shpall, Elizabeth J and Fowlkes, Natalie Wall and Chen, Ken and Rezvani, Katayoun},
  title = {Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {11},
  pages = {2069--2088.e11},
  doi = {10.1016/j.ccell.2025.07.021}
}
Kostenlos starten →